Interview with Jan-Willem Eleveld, Vice President, Counsulting & Services,…
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV…
Address: 302, Level 3, Damansara Uptown 2, 2 Jalan SS21/37, 47400 Petaling Jaya, Selangor,Malaysia
Tel: 603 7710 7380
Web: http://www.imshealth.com/portal/site/ims
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. We offer a variety of solutions to help clients understand the marketplace, improve marketing effectiveness and optimize sales productivity. With a presence in more than 100 countries and over 55 years of experience, IMS applies leading-edge technologies to transform billions of pharmaceutical transactions collected from thousands of sources into strategic insights. Interpreted and analyzed by IMS experts, these insights are an unmatched source of trends and perspectives about the pharmaceutical marketplace – precise market intelligence that can be translated into action.
Commercial Implementation Services: We help meet the challenges of commercial information management, with cutting-edge solutions in reporting and analytics, and operations and compensation outsourcing.
Managed Markets Services: With more than three-quarters of U.S. prescriptions underwritten by third-party payers, we’re the ones to call to help meet contracting, compliance and systems challenges.
Market Research Services: We not only deliver views of market position, but also provide related services — including outsourcing of key market research processes.
We apply Evidence-Based ConsultingSM that can have an immediate impact on the business and market performance of our clients. We help to strengthen portfolios, optimize product launches, mount superior marketing efforts, forge more productive alliances and optimize sales force structure and deployment.
Product & Portfolio Strategy
Companies that don’t plan for the future don’t have one. We help keep the compass pointed in the right direction.
Commercial Effectiveness
A surprisingly low percentage of pharmaceutical brands outperform expectations. We help clients gain access to that elite club.
Pricing & Market Access
There’s both an art and a science to launching new products and ensuring optimal market access and price. We understand the complex dynamics shaping the prospects for products in research and development as well as for those already in-market.
You spent most of your career in the pharmaceutical industry with Bristol Meyers Squibb and earlier on for NV…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched…
After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition…
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted…
American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in…
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge…
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as…
Chuwn Leong Ch’ng, CEO of Thunder Print, presents his company’s strategic role within the Malaysian…
Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi…
Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or…
Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the…
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in…